or Try an Advanced Search...

    Genetic Diseases Stocks List

    Symbol Grade Name % Change
    NTRA A Natera, Inc. 0.00
    BPMC B Blueprint Medicines Corporation 0.00
    BDTX B Black Diamond Therapeutics, Inc. 0.00
    STOK B Stoke Therapeutics, Inc. 0.00
    CODX B Co-Diagnostics, Inc. 0.00
    LUMO C Lumos Pharma, Inc. 0.00
    KRYS D Krystal Biotech, Inc. 0.00
    SYBX D Synlogic, Inc. 0.00
    LRMR D Larimar Therapeutics, Inc. 0.00
    INZY F Inozyme Pharma, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biotechnology Disease Rare Genetic Disease Rare Genetic Diseases Biopharmaceutical Cancer Clinical Medicine Medicine Acid Biology Life Sciences Medical Test Pharmacy Rare Diseases Severe Genetic Diseases Tyrosine Kinase Receptors Applied Genetics Ataxia Black Diamond Cancer Treatment

    Related ETFs - A few ETFs which own one or more of the above listed Genetic Diseases stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 8.17
    HELX D Franklin Genomic Advancements ETF 7.09
    PTH D Invesco DWA Healthcare Momentum ETF 5.92
    WDNA D WisdomTree BioRevolution Fund 5.9
    EKG C First Trust Nasdaq Lux Digital Health Solutions ETF 4.33
    View all Genetic Diseases ETFs...
    Compare ETFs
    Compare GNOM to WDNA Compare HELX to EKG Compare PTH to EKG

        Genetic Diseases Stocks Recent News

        Date Stock Title
        May 7 KRYS Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
        May 7 INZY Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
        May 7 BPMC Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
        May 7 KRYS Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
        May 7 KRYS Q1 2024 Krystal Biotech Inc Earnings Call
        May 6 KRYS Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript
        May 6 STOK Analyst Expectations For Stoke Therapeutics's Future
        May 6 BPMC 5 Biotech Stocks Worth Adding to Your Portfolio in 2024
        May 6 KRYS Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024
        May 6 KRYS Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates
        May 6 STOK Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
        May 6 KRYS Krystal Biotech misses top-line and bottom-line estimates; reaffirms FY24 outlook
        May 6 KRYS Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
        May 6 STOK Stoke Therapeutics GAAP EPS of -$0.57, revenue of $4.2M
        May 6 STOK Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
        May 4 BPMC Blueprint Medicines: Rampant Growth Mostly Priced In
        May 3 KRYS Krystal Biotech Q1 2024 Earnings Preview
        May 3 BPMC Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
        May 3 BPMC Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
        May 3 KRYS Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biotechnology Disease Rare Genetic Disease Rare Genetic Diseases Biopharmaceutical Cancer Clinical Medicine Medicine Acid Biology Life Sciences Medical Test Pharmacy Rare Diseases Severe Genetic Diseases Tyrosine Kinase Receptors Applied Genetics Ataxia Black Diamond Cancer Treatment
        Genetic Diseases

        Genetic diseases are disorders caused by changes in genes or chromosomes. These changes can be inherited from a parent or acquired during a person's lifetime. Examples of genetic diseases include cystic fibrosis, sickle cell anemia, and Huntington's disease.

        Browse All Tags